Full-Time
Associate Manager/Manager
Lung Cancer
KMK Consulting, Inc.
201-500 employees
Pharma analytics and consulting services
No salary listed
Boston, MA, USA
In Person
 Data & Analytics (1) |
|---|
Get referred to KMK Consulting, Inc.
See people who can refer or advise you
- The candidate must have 5–6 years of pharmaceutical analytics experience, preferably in commercial analytics, patient analytics, or oncology.
- The candidate must be Boston based.
- The candidate must have strong experience with market sizing, patient analytics, and launch analytics.
- The candidate must be familiar with lung cancer datasets and oncology analytics, including ICLC and NSCLC.
- The candidate must be able to work independently and communicate insights clearly to non-technical stakeholders.
- The candidate must have strong experience with analytical tools such as SQL, Python, R, or similar.
- Build and maintain market sizing models for lung cancer indications, including ICLC and NSCLC.
- Develop launch analytics frameworks to support commercial strategy, early-market planning, and competitive positioning.
- Analyze epidemiology, incidence, prevalence, and treatment pathways to quantify market potential.
- Conduct patient journey analytics covering diagnosis, treatment initiation, switching, and progression.
- Leverage claims, electronic medical record/electronic health record, and real-world datasets to identify patient segments and unmet needs.
- Generate insights to inform targeting, segmentation, and commercial decision-making.
- Work closely with commercial leads, medical teams, and external vendors to ensure analytical accuracy and strategic alignment.
- Present insights confidently to senior stakeholders with varying levels of technical expertise.
- Operate independently in a high-expectation environment and provide proactive recommendations.
- Experience with real-world data, including claims and electronic medical record/electronic health record data.
- Exposure to predictive modeling or data science techniques.
- Prior experience supporting oncology commercial teams.
KMK Consulting, Inc. provides analytics and consulting for life sciences, focusing on pharma and biotech. Its offerings blend software and advisory services to improve planning, commercialization, and value demonstration across the product lifecycle, including Commercial Analytics, HEOR, RWE, Advanced Analytics, Market Research, and Data Services, with flexible delivery models (project work, SaaS, or on-site teams). Customers use KMK to optimize sales force effectiveness, design incentive programs, and generate evidence for drug approval and reimbursement. In 2026 KMK was acquired by Tredence to combine pharma expertise with AI and data engineering, expanding capabilities in research, development, supply chain, and commercial operations.
Company Size
201-500
Company Stage
N/A
Total Funding
N/A
Headquarters
Morris Plains, New Jersey
Founded
2000
Get referred to KMK Consulting, Inc.
See people who can refer or advise you
Simplify's Take
What believers are saying
- Tredence targets healthcare and life sciences at 25% of revenue by 2028.
- June 2026 buyer messaging highlighted cross-selling AI into KMK's pharma client base.
- KMK's Great Place to Work score hit 95% in April 2026.
What critics are saying
- KMK's acquisition by Tredence in June 2026 triggers costly integration and culture clashes.
- Eight-top-ten-pharma concentration leaves revenue exposed if Pfizer, Novartis, or peers rebid.
- Agentic AI services commoditize quickly; Tredence must win fast or lose to Accenture.
What makes KMK Consulting, Inc. unique
- KMK serves eight of the top ten pharma companies, per June 2026 deal materials.
- Its niche spans RWE, HEOR, commercial analytics, and market research across product lifecycles.
- Tredence bought KMK on June 22, 2026 to pair domain depth with agentic AI.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Remote Work Options
Company News
/PRNewswire/ -- Tredence, the world's leading AI and data science solutions company, today announced the acquisition of KMK Consulting, a specialized analytics...